Microspheres are produced by contacting a solution of a macromolecule or small molecule in a solvent with an antisolvent and a counterion, and chilling the solution. The microspheres are useful for preparing pharmaceuticals, nutraceuticals, cosmetic products and the like of defined dimensions.
Compositions and methods to effect the release profile in the transdermal administration of active agents
申请人:——
公开号:US20020004065A1
公开(公告)日:2002-01-10
Compositions and methods for the transdermal delivery of active agents up to a period of seven days or more at substantially a zero-order release rate comprising a pharmaceutically acceptable adhesive matrix and a polymeric plastic material that provides a release rate regulating effect on the active agents.
Neues rechts-drehendes, basisches Derivat des 9,10-Aethano-anthracens, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Präparate
申请人:CIBA-GEIGY AG
公开号:EP0014434A1
公开(公告)日:1980-08-20
Die vorliegende Erfindung betrifft ein neues optisch aktives, basisches Derivat des 9,10-Aethanoanthracens, das S-(+)-x-[ (Methylamino)methyl]-9,10-äthanoanthracen-9 (10H)-äthanol der Formel I
und seine Säureadditionssalze, Verfahren zur Herstellung dieser neuen Stoffe, solche enthaltende pharmazeutische Präparate und ihre Verwendung als Antidepressiva.
本发明涉及一种新的具有光学活性的 9,10-乙桥蒽碱性衍生物,即式 I 的 S-(+)-x-[(甲基氨基)甲基]-9,10-乙桥蒽-9 (10H)-乙醇及其酸加成盐。
及其酸加成盐、这些新物质的制备工艺、含有这些物质的药物制剂以及它们作为抗抑郁剂的用途。
Methods and compositions for administration of TRPV1 agonists
申请人:Neurogesx, Inc.
公开号:EP2907503A1
公开(公告)日:2015-08-19
Compositions are provided that contain a TRPV 1 agonist, such as capsaicin, and a solvent system. Topical application of the composition results in rapid delivery of agonist to the dermis and epidermis. Method of using the compositions for reducing nociceptive nerve fiber function in subjects, and for treatment of capsaicin-responsive conditions are also provided.
Transdermal drug delivery device including an occlusive backing
申请人:Noven Pharmaceuticals, Inc.
公开号:US10231938B2
公开(公告)日:2019-03-19
A transdermal drug delivery system for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric backing layer which can control the delivery rate and profile of the transdermal drug delivery system by adjusting the moisture vapor transmission rate of the polymeric backing layer.